Hospital Pharmacy Europe

JULY 27, 2023

Acne can be managed with broad range of topical and oral agents including antibiotics and even aldosterone receptor antagonists such as spironolactone. The second most effective option was triple therapy containing a topical antibiotic, a topical retinoid and BPO (MD = 38.15, p = 0.95).

Hospitals 52

Hospitals 52

European Pharmaceutical Review

MARCH 5, 2024

International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. Innovative startups and smaller companies show great interest in the fair, which has established itself as a springboard for new developments and products. AI is also discussed in imaging and spectroscopy.

Labelling 89

Labelling FDA 89

The Checkup by Singlecare

MARCH 7, 2024

Here’s a look at niacinamide’s research-backed benefits. Even though both topical and oral versions have shown some promise, more research is necessary to determine whether niacinamide can fight acne without benzoyl peroxide. There’s not a lot of research to back this up. Actually, there are nine reasons. Arora says. “It

Dosage 98

Dosage Compounding Labelling 98

IDStewardship

JUNE 5, 2023

To shed light on this important topic, we had the privilege of interviewing an esteemed expert [ChatGPT by OpenAI] in the field of antimicrobial stewardship. Through their work, they have spearheaded initiatives, developed guidelines, and collaborated with diverse stakeholders to promote effective antimicrobial stewardship practices.

Vaccines 234

Vaccines Hospitals Patient Care 234

The Checkup by Singlecare

JANUARY 16, 2024

Triamcinolone acetonide cream is one of the most popular topical steroids prescribed to treat eczema. Triamcinolone acetonide is one of the most popular topical steroids given for atopic dermatitis, or eczema,” says George Han, MD, Ph.D., a dermatologist at Northwell Health in New Hyde Park, New York. live with this condition.

Insurance Coverage 105

Insurance Coverage FDA Dosage Insurance 105

Pharmaceutical Technology

MARCH 17, 2023

The Lung Cancer Research Foundation (LCRF) has announced a new research partnership with Daiichi Sankyo and AstraZeneca. This collaboration is intended to fund up to three research grants that are focused on antibody-drug conjugates (ADCs) for improving the outcomes for lung cancer patients.

98

98

The Checkup by Singlecare

FEBRUARY 15, 2024

This can include topical skin care products, supplements, dietary changes, and more. However, the research on this is inconsistent. Some researchers have found that fish oil yields positive effects on psoriasis, while others came to a different conclusion. So, what should you eat?

Immunization 105

Immunization Compounding 105

Pharmaceutical Technology

AUGUST 1, 2022

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. They intend to develop vaccines that provide lasting immune responses compared to existing vaccines.

Vaccines 98

Vaccines Immunization 98

Pharmaceutical Technology

JANUARY 17, 2023

Spain’s Hospital Universitario 12 de Octubre researchers, along with the Josep Carreras Leukaemia Research Institute, have developed a new cell therapy based on STAb cells to treat a type of leukaemia. The Spanish Association Against Cancer (AECC) provided funding for the new STAb therapy development. Free Whitepaper.

Hospitals 110

Hospitals Chemotherapy Communication Immunization 110

Pharmaceutical Technology

MAY 10, 2023

This marks a significant development in a tumultuous dispute between the pharmaceutical company and the US government. According to the US government, Gilead had repeatedly refused to license patents related to PrEP research undertaken by the Department of Health and Human Services’ (HHS) Centers for Disease Control and Prevention (CDC).

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies FDA 105

pharmaphorum

JANUARY 6, 2023

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients. Excited to share Med-PaLM, a large language model aligned to the medical domain to generate safe and helpful answers.

136

136

Pharmaceutical Technology

APRIL 14, 2023

Twist Bioscience has introduced Twist T-cell receptor (TCR) and Twist chimeric antigen receptor (CAR) libraries to facilitate the development of cell therapies. Researchers will now be able to speed up the creation of tailor-made libraries that can help in identifying and developing new cell therapies.

98

98

Pharmaceutical Technology

MARCH 29, 2023

Regeneron Pharmaceuticals has collaborated with Sonoma Biotherapeutics to discover, develop and commercialise new regulatory T cell (Treg) therapies for autoimmune diseases. The two companies will together research and develop T cell therapies for Crohn’s disease and ulcerative colitis, as well as two other undisclosed indications.

98

98

Pharmaceutical Technology

FEBRUARY 16, 2023

The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. Under the deal, MD Anderson and Xilis aim to advance the development of drug and discovery projects using the MOS technology.

Communication 96

Communication 96

Blog: Ask a Student Pharmacist

AUGUST 8, 2023

Cristina Peterson, PhD palap005 Tue, 08/08/2023 - 08:01 Expand all + Biography Bio Summary Dr. Peterson is a researcher studying the neuropharmacology of pain and addiction, with an emphasis on the development of safe, non-addictive analgesic medications.

52

52

Pharmaceutical Technology

DECEMBER 5, 2022

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. The hub will connect Queensland scientists with the teams at Sanofi’s mRNA Centre of Excellence in the US and France, putting them at the front of international vaccine development and biomedical research.

Vaccines 98

Vaccines Communication Immunization 98

Pharmaceutical Technology

APRIL 14, 2023

Ginkgo Bioworks (Ginkgo) and the Wisconsin Alumni Research Foundation (WARF) have collaborated to discover next-generation GD2 CAR T-cell therapies to treat solid tumours. Ginkgo will partner with researchers from Wisconsin-Madison to discover new and improved GD2 CAR designs with improved persistence, fitness and proliferation.

105

105

European Pharmaceutical Review

OCTOBER 13, 2022

The research, published in the journal Science Robotics described how the new drug delivery system can transport large protein and small-molecule drugs, like vancomycin, an antibiotic peptide. To solve this problem, the team at MIT developed a multivitamin-sized capsule that tunnels through mucus.

137

137

European Pharmaceutical Review

AUGUST 22, 2023

According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. Theragenix aims to develop the world’s first dry powder gene therapy formulation for bone graft augmentation.

Vaccines 89

Vaccines Packaging 89

Hospital Pharmacy Europe

MAY 22, 2023

Reporting the results in the BMJ , researchers from the University of Southampton said the NIHR-funded trial was the first to provide clinical evidence that spironolactone was effective for the skin condition. There did not seem to be a difference in effectiveness between women who had PCOS and those who did not, the researchers noted.

Hospitals 102

Hospitals 102

Pharmaceutical Technology

JUNE 19, 2023

The pharma company will in-license a small number of gene therapy products and offer research grants to advance them through pre-clinical development. Topic sponsors are not involved in the creation of editorial content. Laurus Labs will be responsible for launching these products in India and emerging markets.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

OCTOBER 25, 2022

Ast ellas Pharma has announced plans to make a strategic investment to back the development of Taysha Gene Therapies’ adeno-associated virus (AAV) development programmes for Rett syndrome and giant axonal neuropathy (GAN). This would allow the companies to boost the development of new therapy options for Rett syndrome and GAN patients.

105

105

The FDA Law Blog

MARCH 6, 2024

The American Conference Institute (“ACI”) will be hosting a series of go-to forums on critical topics including novel therapeutics, cosmetics/personal care products and Paragraph IV disputes. He’ll be speaking on “Bridging the Gap: From Pre-Commercialization Research to Regulatory Approval for Novel Therapeutics and Regenerative Medicines.”

FDA 59

FDA Pharmaceutical Companies Pharmaceutical Companies 59

STAT

JUNE 6, 2023

“It’s really easy to wake up one morning and realize that you might actually be an industrial spy for a foreign government,” said Allen Phelps, CEO of IPTalons, a research security service provider. “Despite what you see in the movies, it is not somebody walking in and saying, ‘Do you want to spy for me?’

83

83

Hospital Pharmacy Europe

JUNE 12, 2023

In addition to blistering, open wounds develop together with extra-cutaneous manifestations, affecting the eyes, oral cavity and many internal organ systems. The FDA approval of VYJUVEK – also known as beremagene geperpavec or B-VEC – provides the first novel topical gene therapy. But how effective is this novel topical therapy?

FDA 96

FDA Labelling Hospitals 96

Pharmaceutical Technology

MARCH 20, 2023

RVAC Medicines has announced a research collaboration with the University of Pennsylvania (Penn) for the discovery and development of mRNA vaccines. The partnership will focus on developing potential new vaccines to treat certain selected autoimmune indications, as well as food allergies.

Vaccines 98

Vaccines Immunization Communication 98

Pharmaceutical Technology

APRIL 21, 2023

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

98

98

Pharmaceutical Technology

NOVEMBER 21, 2022

RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore.

Vaccines 52

Vaccines 52

Pharmaceutical Technology

MAY 4, 2023

Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. Topic sponsors are not involved in the creation of editorial content. This will improve accessibility to services for AAV-mediated gene therapy programmes.

102

102

Pharmaceutical Technology

MAY 30, 2023

As part of an exclusive licensing agreement, Amplo Biotechnology secured access to AAV-ColQ data developed by Professor Kinji Ohno’s laboratory at Nagoya University, which forms the basis of the therapy. It also develops adeno-associate virus-based gene therapies for neuromuscular junction disorders.

97

97

European Pharmaceutical Review

JUNE 26, 2023

There were 61 RWD research opportunities identified, 30 studies initiated and 27 completed in this period. Use of RWE is less established in earlier stages of medicines development, the EMA stated. Real-world evidence (RWE) from these studies can complement evidence from other sources including clinical trials.

Medical Records 79

Medical Records Clinic Management 79

European Pharmaceutical Review

JULY 13, 2023

3 With established drug development pathways, we are accustomed to a rigid structure of translation from bench to bedside. While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. Just an excuse?

Compounding 87

Compounding Documentation Insurance Immunization 87

pharmaphorum

AUGUST 16, 2021

UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed second-round financing that will help fund clinical development of its psilocybin-based therapies. The post Beckley Psytech raises $80m for psychedelic meds development appeared first on.

Compounding 135

Compounding 135

Pharmaceutical Technology

OCTOBER 19, 2022

Akouos focuses on developing adeno-associated viral gene therapies to treat inner ear conditions, including sensorineural hearing loss. Topic sponsors are not involved in the creation of editorial content. The post Lilly agrees to acquire gene therapy developer Akouos for $610m appeared first on Pharmaceutical Technology.

119

119

Pharmaceutical Technology

APRIL 20, 2023

Situated at the hub of the country’s northeastern pharmaceutical corridor, the new facility is staffed by research, application and formulation specialists. It also aims to contribute to the pharmaceutical sector by facilitating cross-industry partnerships and research-based product development.

Dosage 52

Dosage 52

Pharmaceutical Technology

APRIL 17, 2023

The company will provide regulatory advice to Incannex, and manage clinical trials to develop CannQuit and ReneCann products to treat addiction and immune-disordered skin diseases. The company will help in managing the clinical trials of the products once the regulators provide approvals for the proposed research and development programmes.

Immunization 52

Immunization Pharmaceutical Companies Pharmaceutical Companies FDA 52

Pharmaceutical Technology

MARCH 10, 2023

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. Personalised medicines will also be developed at the centre.

Communication 105

Communication 105